Bain Capital Life Sciences Investors, LLC Annexon, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $557 Million
- Q3 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 8,449,748 shares of ANNX stock, worth $46.1 Million. This represents 8.98% of its overall portfolio holdings.
Number of Shares
8,449,748
Previous 8,449,208
0.01%
Holding current value
$46.1 Million
Previous $41.4 Million
20.82%
% of portfolio
8.98%
Previous 8.47%
Shares
8 transactions
Others Institutions Holding ANNX
# of Institutions
146Shares Held
102MCall Options Held
178KPut Options Held
159K-
Satter Management Co., L.P.7.41MShares$40.4 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$38.2 Million1.32% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$36 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$35.1 Million2.49% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.33MShares$29.1 Million0.09% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $260M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...